|
Indications & Dosage INDICATIONS AND USAGE and DOSAGE AND ADMINISTRATION sections of the prescribing information for ZITHROMAX (azithromycin for oral suspension) 100 mg/ 5 mL and 200 mg/ 5 mL bottles.
Safety in HIV-Infected Pediatric Patients Safety and efficacy of azithromycin for the prevention or treatment of MAC in HIV-infected children have not been established. Safety data are available for 72 children 5 months to 18 years of age (mean 7 years) who received azithromycin for treatment of opportunistic infections. The mean duration of therapy was 242 days (range 3-2004 days) at doses of <1 to 52 mg/ kg/ day (mean 12 mg/ kg/ day). Adverse events were similar to those observed in the adult population, most of which involved the gastrointestinal tract. Treatment related reversible hearing impairment in children was observed in 4 subjects (5.6%). Two (2.8%) children prematurely discontinued treatment due to side effects: one due to back pain and one due to abdominal pain, hot and cold flushes, dizziness, headache, and numbness. A third child discontinued due to a laboratory abnormality (eosinophilia). The protocols upon which these data are based specified a daily dose of 10-20 mg/ kg/ day (oral and/ or i. v.) of azithromycin. Text Continues Below

Geriatric Use Pharmacokinetic parameters in older volunteers (65-85 years old) were similar to those in younger volunteers (18-40 years old) for the 5-day therapeutic regimen. Dosage adjustment does not appear to be necessary for older patients with normal renal and hepatic function receiving treatment with this dosage regimen. (See CLINICAL PHARMACOLOGY.) In multiple-dose clinical trials of oral azithromycin, 9% of patients were at least 65 years of age (458/ 4949) and 3% of patients (144/ 4949) were at least 75 years of age. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. ZITHROMAX ® 600 mg tablets contain 2.1 mg of sodium per tablet. ZITHROMAX ® for oral suspension 1 gram single-dose packets contain 37.0 mg of sodium per packet. Page: 1 | 2 | 3 | 4 | 5 | Next >>
|